Decade of OPERA Data Supports Early Ocrelizumab Treatment Initiation in Relapsing Multiple Sclerosis
A newly published study showed that patients with relapsing multiple sclerosis (RMS) who started ocrelizumab (Ocrevus; ...
Clene has filed an NDA seeking accelerated approval of CNM-Au8 for ALS, following 2 missed primary trial endpoints and years ...
This week on NeurologyLive, there are a number of hot topics that we will be post ...
The NeurologyLive ® Editorial Advisory Board consists of physicians, clinicians, and researchers across the breadth of neurology who help to define the trends and drive the conversations in their ...
Intravenousocrelizumab (Ocrevus; Genentech) demonstrated noninferiority to oral fingolimod (Gilenya; Novartis) for ...
Welcome to NeurologyLive® Brain Games! This weekly quiz series, which goes live every Sunday morning, will feature questions ...
Welcome to NeurologyLive® 's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive 's widespread coverage in ...
This episode, "Follow-Up Care and the Caregiver's Role in Managing Agitation," features the panel closing the series with a ...
Pivotal AFFINITY DUCHENNE results showed microdystrophin expression above the prespecified threshold in 93% of evaluable ...
The FDA was busy in September 2026, issuing a number of decisions on potential new therapies, including approvals, clearances ...
New analyses found differences in functional outcomes over 2 years among patients aged 8 to 12 years treated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results